CMO of Maze Therapeutics sold company shares due to vesting, with filings required by the SEC and trading on Nasdaq.
1 report, 1 independent
Updated Sep 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
CMO of Maze Therapeutics sold company shares due to vesting, with filings required by the SEC and trading on Nasdaq.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Silicon Laboratories stock traded on Nasdaq and required SEC filings on September 8, 2026.
- CNO Financial Group, Inc. filed insider trading disclosures with the SEC.
- Insider sold shares of LegalZoom and filed the stock transaction with the SEC.
- Casella Waste Systems disclosed that director Michael Burke sold company stock in a filing with the SEC.
- Repay Holdings Corporation disclosed a transaction in an SEC filing and trades on Nasdaq.